1. Absence of evidence of parvovirus B19 transmission by plasma‐derived clotting concentrates derived from B19V nucleic acid technology–tested plasma and including effective steps for the inactivation or removal of nonenveloped viruses. Issue 5 (9th May 2013) Authors: Gajardo, Rodrigo; Roth, Nathan J.; Lee, Douglas C.; Jorquera, Juan I. Journal: Transfusion Issue: Volume 53:Issue 5(2013) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of 52 240 source plasma donors of convalescent COVID‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation. Issue 5 (11th July 2022) Authors: Schmidt, Amy E.; Vogel, Peter; Chastain, Carrie A.; Barnes, Thomas; Roth, Nathan J.; Simon, Toby L. Journal: Journal of clinical apheresis Issue: Volume 37:Issue 5(2022) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Choice of parvovirus model for validation studies influences the interpretation of the effectiveness of a virus filtration step. (July 2019) Authors: Nowak, Thomas; Popp, Birgit; Roth, Nathan J. Journal: Biologicals Issue: Volume 60(2019) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effective coronavirus reduction by various production steps during the manufacture of plasma‐derived medicinal products. Issue 6 (16th June 2020) Authors: Schräder, Tobias; Koch, Julia; Ross, Rachael; Schäfer, Wolfram; Keiner, Björn; Roth, Nathan J.; Widmer, Eleonora Journal: Transfusion Issue: Volume 60:Issue 6(2020) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effective inactivation of a wide range of viruses by pasteurization. Issue 1 (16th November 2017) Authors: Gröner, Albrecht; Broumis, Connie; Fang, Randel; Nowak, Thomas; Popp, Birgit; Schäfer, Wolfram; Roth, Nathan J. Journal: Transfusion Issue: Volume 58:Issue 1(2018) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hepatitis E virus: Efficacy of pasteurization of plasma‐derived VWF/FVIII concentrate determined by pig bioassay. Issue 4 (19th February 2021) Authors: Dähnert, Lisa; Schlosser, Josephine; Fast, Christine; Fröhlich, Andreas; Gröner, Albrecht; Lange, Elke; Roth, Nathan J.; Schäfer, Wolfram; Schröder, Charlotte; Eiden, Martin; Groschup, Martin H. Journal: Transfusion Issue: Volume 61:Issue 4(2021) Page Start: 1266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of the isoelectric point of model parvoviruses on viral retention in anion‐exchange chromatography. Issue 1 (12th September 2020) Authors: Leisi, Remo; Wolfisberg, Raphael; Nowak, Thomas; Caliaro, Oliver; Hemmerle, Andreas; Roth, Nathan J.; Ros, Carlos Journal: Biotechnology and bioengineering Issue: Volume 118:Issue 1(2021) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Low hepatitis E virus RNA prevalence in a large‐scale survey of United States source plasma donors. Issue 12 (21st August 2017) Authors: Roth, Nathan J.; Schäfer, Wolfram; Alexander, Rick; Elliott, Kevin; Elliott‐Browne, Wlenyeno; Knowles, Jonathan; Wenzel, Jürgen J.; Simon, Toby L. Journal: Transfusion Issue: Volume 57:Issue 12(2017) Page Start: 2958 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers. Issue 11 (19th August 2020) Authors: Roth, Nathan J.; Dichtelmüller, Herbert O.; Fabbrizzi, Fabrizio; Flechsig, Eckhard; Gröner, Albrecht; Gustafson, Mary; Jorquera, Juan I.; Kreil, Thomas R.; Misztela, Dominika; Moretti, Elisa; Moscardini, Mila; Poelsler, Gerhard; More, John; Roberts, Peter; Wieser, Andreas; Gajardo, Rodrigo Journal: Transfusion Issue: Volume 60:Issue 11(2020) Page Start: 2661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pathogen safety and characterisation of a highly purified human alpha1-proteinase inhibitor preparation. (May 2017) Authors: Kee, Scott; Weber, David; Popp, Birgit; Nowak, Thomas; Schäfer, Wolfram; Gröner, Albrecht; Roth, Nathan J. Journal: Biologicals Issue: Volume 47(2017) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗